A clinical trial to study the effect of triphala lauha in the patients of Amlapitta( gastric disorders like heartburn,indigestion, nausea etc)

To study the efficacy of triphala lauha in disintegration of aetiopathogenesis of Amlapitta

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011875

Enrollment

Registered

2018-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of Amlapitta disease

Interventions

Intervention1: Triphala Lauha: 250 mg BD for 45 days Fixed diet Regimen Control Intervention1: No Treatment: Fixed Diet Regimen

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex 2. Patients with age group between 25-55 years 3. Patients with symptoms of Amlapitta like Amlaudgara(sour belching)Daha(burning sensation )Chhardi(vomiting) Shoola(pain) 4.Patients having symptoms of Amlapitta for more than 7 days 5.Patients taking modern medicines

Exclusion criteria

Exclusion criteria: 1.Patients of age below 25 years and more than 55 years 2.Patients of severe vomiting and dehydration 3.Pregnant women and lactating mother 4.Patients with gastric malignancy 5.Patients having addiction of alcohol 6.Patients who recently undergone gastrointestinal surgery

Design outcomes

Primary

Measure	Time frame
Relief in symptoms of amlapittaTimepoint: Every 15 days	—

Secondary

Measure	Time frame
Relief in symptoms of AmlapittaTimepoint: every 15 days	—

Countries

India

Contacts

Public ContactProf Dr Vidula Gujjarwar

Ch. Brahm Prakash Ayurved Charak Sansthan Khera Dabar, Najafgarh

shreemahalaxmi1969@gmail.com9990174348

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026